Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

397
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
397
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

735
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
735
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

707
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
707
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

786
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
786
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

337
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
337
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

384
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
384

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurotensin Receptor 1 Regulates HER4 Tyrosine Phosphorylation in Lung Cancer Cells.

Biology·2026
Same author

Role of serine/threonine phosphatases 1 and 2A in pancreatic acinar fluid and electrolyte secretion.

American journal of physiology. Gastrointestinal and liver physiology·2026
Same author

Gastrin-Releasing Peptide Receptors Stimulate MAPK-Mediated Growth of Lung Cancer Cells by Transactivating HER4 in a Neuregulin-1, MAP Kinase-Dependent Manner Requiring Activation of the ROS-System.

Biology·2025
Same author

Surgical Strategies for Tumors of the Pancreas and Duodenum.

Cancers·2025
Same author

Bombesin Receptor Subtype-3 Regulates Tumor Growth by HER2 Tyrosine Phosphorylation in a Reactive Oxygen Species-Dependent Manner in Lung Cancer Cells.

Targets (Basel)·2025
Same author

Elucidation of roles of serine/threonine phosphatases PP1 and PP2A in mediating CCK-stimulated growth and enzyme secretion in pancreatic acinar cells.

American journal of physiology. Gastrointestinal and liver physiology·2025

Related Experiment Video

Updated: Jan 7, 2026

Ileectomy-induced Bile Overaccumulation in Mouse Intestine
06:55

Ileectomy-induced Bile Overaccumulation in Mouse Intestine

Published on: August 21, 2017

9.9K

Current Medical Controversies in Zollinger-Ellison Syndrome.

Robert T Jensen1, Irene Ramos-Alvarez1, Jeffrey A Norton2

  • 1Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Biomedicines
|December 30, 2025
PubMed
Summary
This summary is machine-generated.

Zollinger-Ellison syndrome (ZES) management involves ongoing medical and surgical controversies. This review analyzes unresolved issues in ZES, including diagnosis, treatment, and long-term care for gastrinomas and other neuroendocrine tumors.

Keywords:
MEN1PRRTZollinger–Ellison syndromechemotherapygastric carcinoidsgastrinomahypergastrinemialifelong acid antisecretory drug treatmentpancreatic neuroendocrine tumor/neoplasm syndromesomatostatin receptor imaging

More Related Videos

Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors
03:37

Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors

Published on: December 20, 2024

878

Related Experiment Videos

Last Updated: Jan 7, 2026

Ileectomy-induced Bile Overaccumulation in Mouse Intestine
06:55

Ileectomy-induced Bile Overaccumulation in Mouse Intestine

Published on: August 21, 2017

9.9K
Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors
03:37

Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors

Published on: December 20, 2024

878

Area of Science:

  • Endocrinology
  • Gastroenterology
  • Oncology

Background:

  • Zollinger-Ellison syndrome (ZES) is a neuroendocrine tumor syndrome characterized by gastrin secretion, leading to severe acid-peptic disorders.
  • It is the most common malignant pancreatic neuroendocrine tumor (pNET) syndrome, presenting unique management challenges.

Purpose of the Study:

  • To analyze current, unresolved medical controversies in Zollinger-Ellison syndrome (ZES) management.
  • To explore the basis of these controversies and potential resolutions from recent studies.

Main Methods:

  • Review of current medical controversies in ZES management.
  • Analysis of recent studies on gastrinomas, other pNET syndromes, and neuroendocrine tumors (NETs).

Main Results:

  • Controversies identified in long-term acid control, diagnosis, management of gastric carcinoids in MEN1/ZES, genotype-phenotype correlations, imaging for gastrinomas, tumor ablation, and metastatic disease treatment.
  • Insights into the basis of these controversies and potential resolutions are discussed.

Conclusions:

  • Understanding the basis of ZES-related controversies is crucial for advancing patient care.
  • Recent research offers potential pathways to resolve these ongoing management challenges.